nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—FABP3—prostate gland—prostate cancer	0.0238	0.0895	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—prostate gland—prostate cancer	0.0212	0.0798	CbGeAlD
Alpha-Linolenic Acid—FADS2—prostate gland—prostate cancer	0.018	0.0679	CbGeAlD
Alpha-Linolenic Acid—FABP3—renal system—prostate cancer	0.0162	0.061	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—renal system—prostate cancer	0.0144	0.0544	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—urethra—prostate cancer	0.0142	0.0534	CbGeAlD
Alpha-Linolenic Acid—FADS1—prostate gland—prostate cancer	0.0141	0.0533	CbGeAlD
Alpha-Linolenic Acid—FADS2—epithelium—prostate cancer	0.0132	0.0499	CbGeAlD
Alpha-Linolenic Acid—FADS2—renal system—prostate cancer	0.0123	0.0463	CbGeAlD
Alpha-Linolenic Acid—FADS2—urethra—prostate cancer	0.0121	0.0454	CbGeAlD
Alpha-Linolenic Acid—FADS1—seminal vesicle—prostate cancer	0.012	0.045	CbGeAlD
Alpha-Linolenic Acid—FABP3—testis—prostate cancer	0.0105	0.0394	CbGeAlD
Alpha-Linolenic Acid—TRPV1—epithelium—prostate cancer	0.0104	0.0391	CbGeAlD
Alpha-Linolenic Acid—TRPV1—renal system—prostate cancer	0.00963	0.0363	CbGeAlD
Alpha-Linolenic Acid—FADS1—urethra—prostate cancer	0.00946	0.0357	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—testis—prostate cancer	0.00933	0.0352	CbGeAlD
Alpha-Linolenic Acid—Azelaic Acid—SRD5A2—prostate cancer	0.00866	0.443	CrCbGaD
Alpha-Linolenic Acid—Icosapent—ACSL4—prostate cancer	0.0085	0.435	CrCbGaD
Alpha-Linolenic Acid—FADS2—testis—prostate cancer	0.00794	0.0299	CbGeAlD
Alpha-Linolenic Acid—FADS1—bone marrow—prostate cancer	0.00728	0.0274	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—lymph node—prostate cancer	0.00677	0.0255	CbGeAlD
Alpha-Linolenic Acid—TRPV1—testis—prostate cancer	0.00623	0.0235	CbGeAlD
Alpha-Linolenic Acid—FADS1—testis—prostate cancer	0.00623	0.0235	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Abiraterone—prostate cancer	0.00603	0.0221	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Abiraterone—prostate cancer	0.00591	0.0216	CcSEcCtD
Alpha-Linolenic Acid—FADS2—lymph node—prostate cancer	0.00575	0.0217	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Nilutamide—prostate cancer	0.00551	0.0202	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Flutamide—prostate cancer	0.00549	0.0201	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Nilutamide—prostate cancer	0.0054	0.0197	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Cabazitaxel—prostate cancer	0.00464	0.017	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Cabazitaxel—prostate cancer	0.00454	0.0166	CcSEcCtD
Alpha-Linolenic Acid—FADS1—lymph node—prostate cancer	0.00451	0.017	CbGeAlD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Bicalutamide—prostate cancer	0.00398	0.0145	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Bicalutamide—prostate cancer	0.0039	0.0143	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Estradiol valerate/Dienogest—prostate cancer	0.00346	0.0127	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Degarelix—prostate cancer	0.00329	0.012	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Estrone—prostate cancer	0.00324	0.0118	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Cabazitaxel—prostate cancer	0.0031	0.0113	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Cabazitaxel—prostate cancer	0.00304	0.0111	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Abiraterone—prostate cancer	0.0029	0.0106	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Abiraterone—prostate cancer	0.00284	0.0104	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00283	0.0103	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Abiraterone—prostate cancer	0.00282	0.0103	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Degarelix—prostate cancer	0.00269	0.00983	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Bicalutamide—prostate cancer	0.00266	0.00973	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Nilutamide—prostate cancer	0.00265	0.00968	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Nilutamide—prostate cancer	0.0026	0.0095	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Nilutamide—prostate cancer	0.00257	0.00941	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Flutamide—prostate cancer	0.00256	0.00937	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.00249	0.0091	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.00244	0.00892	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Estramustine—prostate cancer	0.0024	0.00877	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Degarelix—prostate cancer	0.00232	0.00848	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Degarelix—prostate cancer	0.0023	0.0084	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Estrone—prostate cancer	0.00229	0.00838	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Ethinyl Estradiol—prostate cancer	0.00225	0.00822	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Cabazitaxel—prostate cancer	0.00223	0.00815	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00219	0.00799	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Cabazitaxel—prostate cancer	0.00216	0.00792	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Estramustine—prostate cancer	0.00216	0.00788	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Estradiol—prostate cancer	0.00215	0.00786	CcSEcCtD
Alpha-Linolenic Acid—Rash—Estramustine—prostate cancer	0.00214	0.00782	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Estramustine—prostate cancer	0.00214	0.00781	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Nilutamide—prostate cancer	0.00213	0.00778	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Flutamide—prostate cancer	0.00212	0.00775	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Abiraterone—prostate cancer	0.00209	0.00766	CcSEcCtD
Alpha-Linolenic Acid—Rash—Abiraterone—prostate cancer	0.00208	0.00759	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Abiraterone—prostate cancer	0.00207	0.00759	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Estrone—prostate cancer	0.00206	0.00753	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Mitoxantrone—prostate cancer	0.00204	0.00748	CcSEcCtD
Alpha-Linolenic Acid—Rash—Estrone—prostate cancer	0.00204	0.00747	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Estrone—prostate cancer	0.00204	0.00746	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Mitoxantrone—prostate cancer	0.002	0.00732	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.002	0.00731	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Nilutamide—prostate cancer	0.00191	0.00699	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Bicalutamide—prostate cancer	0.00191	0.00699	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Flutamide—prostate cancer	0.0019	0.00696	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Degarelix—prostate cancer	0.0019	0.00695	CcSEcCtD
Alpha-Linolenic Acid—Rash—Nilutamide—prostate cancer	0.0019	0.00694	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Nilutamide—prostate cancer	0.00189	0.00693	CcSEcCtD
Alpha-Linolenic Acid—Rash—Flutamide—prostate cancer	0.00189	0.00691	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Flutamide—prostate cancer	0.00189	0.0069	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00187	0.00686	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Bicalutamide—prostate cancer	0.00186	0.00679	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Goserelin—prostate cancer	0.00185	0.00677	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Conjugated Estrogens—prostate cancer	0.00183	0.0067	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.0018	0.00657	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Conjugated Estrogens—prostate cancer	0.0018	0.00657	CcSEcCtD
Alpha-Linolenic Acid—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00178	0.00652	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00178	0.00651	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Degarelix—prostate cancer	0.00171	0.00625	CcSEcCtD
Alpha-Linolenic Acid—Rash—Degarelix—prostate cancer	0.00169	0.0062	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Degarelix—prostate cancer	0.00169	0.00619	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Etoposide—prostate cancer	0.00167	0.00609	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Cabazitaxel—prostate cancer	0.00161	0.00589	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00158	0.0058	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Ethinyl Estradiol—prostate cancer	0.00157	0.00574	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Bicalutamide—prostate cancer	0.00154	0.00562	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Goserelin—prostate cancer	0.00151	0.00552	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.0015	0.00547	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Estradiol—prostate cancer	0.00147	0.00537	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Estradiol—prostate cancer	0.00144	0.00525	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Epirubicin—prostate cancer	0.00143	0.00524	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Docetaxel—prostate cancer	0.00141	0.00517	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Docetaxel—prostate cancer	0.00138	0.00506	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Bicalutamide—prostate cancer	0.00138	0.00505	CcSEcCtD
Alpha-Linolenic Acid—Rash—Bicalutamide—prostate cancer	0.00137	0.00501	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Capecitabine—prostate cancer	0.00137	0.005	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Bicalutamide—prostate cancer	0.00137	0.005	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Capecitabine—prostate cancer	0.00134	0.0049	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Mitoxantrone—prostate cancer	0.00134	0.0049	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Goserelin—prostate cancer	0.00133	0.00486	CcSEcCtD
Alpha-Linolenic Acid—Eructation—Doxorubicin—prostate cancer	0.00133	0.00485	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00132	0.00482	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Ethinyl Estradiol—prostate cancer	0.0013	0.00475	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00129	0.00472	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Goserelin—prostate cancer	0.00129	0.00472	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Conjugated Estrogens—prostate cancer	0.00128	0.00468	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Estradiol—prostate cancer	0.0012	0.00438	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Prednisone—prostate cancer	0.00119	0.00437	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.00117	0.00427	CcSEcCtD
Alpha-Linolenic Acid—Rash—Ethinyl Estradiol—prostate cancer	0.00116	0.00423	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00116	0.00423	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00112	0.00408	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Etoposide—prostate cancer	0.00111	0.00407	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Goserelin—prostate cancer	0.00107	0.00391	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Conjugated Estrogens—prostate cancer	0.00106	0.00387	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Estradiol—prostate cancer	0.00105	0.00385	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Estradiol—prostate cancer	0.00103	0.00378	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Estradiol—prostate cancer	0.00102	0.00375	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Mitoxantrone—prostate cancer	0.000982	0.00359	CcSEcCtD
Alpha-Linolenic Acid—Ethanolamine Oleate—CYP2E1—prostate cancer	0.00098	0.0501	CrCbGaD
Alpha-Linolenic Acid—Vomiting—Goserelin—prostate cancer	0.00096	0.00351	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Mitoxantrone—prostate cancer	0.000954	0.00349	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000953	0.00349	CcSEcCtD
Alpha-Linolenic Acid—Rash—Goserelin—prostate cancer	0.000952	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Goserelin—prostate cancer	0.000951	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000951	0.00348	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Docetaxel—prostate cancer	0.000945	0.00346	CcSEcCtD
Alpha-Linolenic Acid—Rash—Conjugated Estrogens—prostate cancer	0.000943	0.00345	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000942	0.00345	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000933	0.00341	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Etoposide—prostate cancer	0.000928	0.00339	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Docetaxel—prostate cancer	0.000925	0.00338	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Capecitabine—prostate cancer	0.000915	0.00335	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Capecitabine—prostate cancer	0.000896	0.00328	CcSEcCtD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000882	0.00323	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000864	0.00316	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Estradiol—prostate cancer	0.000847	0.0031	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Prednisone—prostate cancer	0.000815	0.00298	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Etoposide—prostate cancer	0.000801	0.00293	CcSEcCtD
Alpha-Linolenic Acid—Dihomo-gamma-linolenic acid—PTGS2—prostate cancer	0.000797	0.0408	CrCbGaD
Alpha-Linolenic Acid—Constipation—Etoposide—prostate cancer	0.000794	0.0029	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Docetaxel—prostate cancer	0.000771	0.00282	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Estradiol—prostate cancer	0.000761	0.00278	CcSEcCtD
Alpha-Linolenic Acid—Rash—Estradiol—prostate cancer	0.000755	0.00276	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Estradiol—prostate cancer	0.000754	0.00276	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Mitoxantrone—prostate cancer	0.000709	0.00259	CcSEcCtD
Alpha-Linolenic Acid—Rash—Mitoxantrone—prostate cancer	0.000703	0.00257	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Mitoxantrone—prostate cancer	0.000703	0.00257	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Docetaxel—prostate cancer	0.000679	0.00248	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000666	0.00244	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Prednisone—prostate cancer	0.000665	0.00243	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Docetaxel—prostate cancer	0.00066	0.00241	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Capecitabine—prostate cancer	0.000657	0.0024	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Etoposide—prostate cancer	0.000657	0.0024	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000645	0.00236	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Capecitabine—prostate cancer	0.000639	0.00234	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Epirubicin—prostate cancer	0.000637	0.00233	CcSEcCtD
Alpha-Linolenic Acid—Icosapent—PTGS2—prostate cancer	0.000626	0.032	CrCbGaD
Alpha-Linolenic Acid—Dysgeusia—Epirubicin—prostate cancer	0.000624	0.00228	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Etoposide—prostate cancer	0.00059	0.00216	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Doxorubicin—prostate cancer	0.00059	0.00216	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Prednisone—prostate cancer	0.000585	0.00214	CcSEcCtD
Alpha-Linolenic Acid—Rash—Etoposide—prostate cancer	0.000585	0.00214	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Etoposide—prostate cancer	0.000585	0.00214	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Doxorubicin—prostate cancer	0.000578	0.00211	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Prednisone—prostate cancer	0.000569	0.00208	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Docetaxel—prostate cancer	0.000546	0.002	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Capecitabine—prostate cancer	0.000528	0.00193	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Epirubicin—prostate cancer	0.00052	0.0019	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Docetaxel—prostate cancer	0.00049	0.00179	CcSEcCtD
Alpha-Linolenic Acid—Rash—Docetaxel—prostate cancer	0.000486	0.00178	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Docetaxel—prostate cancer	0.000486	0.00178	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Doxorubicin—prostate cancer	0.000481	0.00176	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Capecitabine—prostate cancer	0.000475	0.00174	CcSEcCtD
Alpha-Linolenic Acid—Rash—Capecitabine—prostate cancer	0.000471	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Prednisone—prostate cancer	0.000471	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Capecitabine—prostate cancer	0.00047	0.00172	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Epirubicin—prostate cancer	0.000458	0.00167	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000449	0.00164	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Epirubicin—prostate cancer	0.000445	0.00163	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Doxorubicin—prostate cancer	0.000424	0.00155	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Prednisone—prostate cancer	0.000423	0.00155	CcSEcCtD
Alpha-Linolenic Acid—Rash—Prednisone—prostate cancer	0.000419	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Prednisone—prostate cancer	0.000419	0.00153	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000416	0.00152	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Doxorubicin—prostate cancer	0.000412	0.00151	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Epirubicin—prostate cancer	0.000368	0.00135	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Doxorubicin—prostate cancer	0.000341	0.00125	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Epirubicin—prostate cancer	0.000331	0.00121	CcSEcCtD
Alpha-Linolenic Acid—Rash—Epirubicin—prostate cancer	0.000328	0.0012	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Epirubicin—prostate cancer	0.000328	0.0012	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000308	0.000697	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000308	0.000697	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTA2—prostate cancer	0.000307	0.000695	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA3—prostate cancer	0.000307	0.000695	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SULT1E1—prostate cancer	0.000307	0.000695	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SRD5A1—prostate cancer	0.000307	0.000695	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Doxorubicin—prostate cancer	0.000306	0.00112	CcSEcCtD
Alpha-Linolenic Acid—Rash—Doxorubicin—prostate cancer	0.000303	0.00111	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Doxorubicin—prostate cancer	0.000303	0.00111	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SULT1A1—prostate cancer	0.000303	0.000686	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ABCG5—prostate cancer	0.000303	0.000686	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000302	0.000683	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000298	0.000675	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTA1—prostate cancer	0.000296	0.00067	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000294	0.000665	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000293	0.000664	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—HPGDS—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ACSL4—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTO1—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HSD3B2—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HSD17B3—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NAT2—prostate cancer	0.000293	0.000663	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP2C19—prostate cancer	0.000291	0.000659	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	0.00029	0.000656	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000289	0.000655	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTT1—prostate cancer	0.000284	0.000643	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ACHE—prostate cancer	0.000284	0.000643	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000283	0.000641	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000281	0.000637	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP2A6—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PHGDH—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP2C18—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—LRP2—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PLCB2—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—UMPS—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ARG2—prostate cancer	0.000281	0.000636	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.00028	0.000633	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000279	0.000632	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000276	0.000626	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—LDHB—prostate cancer	0.000275	0.000623	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—P4HB—prostate cancer	0.000275	0.000623	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKR1C3—prostate cancer	0.000273	0.000618	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PRKCQ—prostate cancer	0.000272	0.000615	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PRKACB—prostate cancer	0.000272	0.000615	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP3A5—prostate cancer	0.00027	0.000612	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP17A1—prostate cancer	0.000269	0.000609	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLAUR—prostate cancer	0.000268	0.000608	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC22A1—prostate cancer	0.000268	0.000606	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000267	0.000605	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000265	0.0006	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000265	0.000599	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000264	0.000597	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SULT2A1—prostate cancer	0.000261	0.000591	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA3—prostate cancer	0.000261	0.000591	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PDHA1—prostate cancer	0.000261	0.000591	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TCN2—prostate cancer	0.000261	0.000591	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—UCP3—prostate cancer	0.000261	0.000591	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MED12—prostate cancer	0.000257	0.000581	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA2—prostate cancer	0.000256	0.00058	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000255	0.000577	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GNG5—prostate cancer	0.000255	0.000577	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—VAV3—prostate cancer	0.000249	0.000564	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC22A3—prostate cancer	0.000249	0.000564	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HSD3B1—prostate cancer	0.000249	0.000564	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA3—prostate cancer	0.000245	0.000555	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SLC5A5—prostate cancer	0.000244	0.000553	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ITPR1—prostate cancer	0.000241	0.000547	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000241	0.000547	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000241	0.000546	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA4—prostate cancer	0.000239	0.00054	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP2E1—prostate cancer	0.000239	0.00054	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TBXAS1—prostate cancer	0.000239	0.00054	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NQO1—prostate cancer	0.000236	0.000534	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—HPGDS—prostate cancer	0.000234	0.00053	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000233	0.000528	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000233	0.000528	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP2C19—prostate cancer	0.000233	0.000527	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA2—prostate cancer	0.000233	0.000527	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—TH—prostate cancer	0.000233	0.000527	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000231	0.000523	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP3A4—prostate cancer	0.00023	0.000521	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ABCG5—prostate cancer	0.00023	0.00052	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SULT1A1—prostate cancer	0.00023	0.00052	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000229	0.000518	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ACHE—prostate cancer	0.000227	0.000514	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTT1—prostate cancer	0.000227	0.000514	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP1B1—prostate cancer	0.000226	0.000512	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000225	0.00051	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTA1—prostate cancer	0.000224	0.000508	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP2A6—prostate cancer	0.000224	0.000508	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000223	0.000506	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTO1—prostate cancer	0.000222	0.000502	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HSD3B2—prostate cancer	0.000222	0.000502	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NAT2—prostate cancer	0.000222	0.000502	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000222	0.000502	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GGT1—prostate cancer	0.000219	0.000496	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKR1C3—prostate cancer	0.000218	0.000494	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PRKACB—prostate cancer	0.000217	0.000492	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NCOA1—prostate cancer	0.000216	0.000489	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP17A1—prostate cancer	0.000215	0.000487	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000214	0.000485	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ITGB3—prostate cancer	0.000214	0.000484	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000213	0.000483	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP2C18—prostate cancer	0.000213	0.000482	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—LRP2—prostate cancer	0.000213	0.000482	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP19A1—prostate cancer	0.000213	0.000482	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PLCB2—prostate cancer	0.000213	0.000482	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000212	0.00048	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—P4HB—prostate cancer	0.000209	0.000472	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—RXRA—prostate cancer	0.000205	0.000465	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA2—prostate cancer	0.000205	0.000464	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC22A1—prostate cancer	0.000203	0.000459	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000201	0.000454	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.0002	0.000452	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—COMT—prostate cancer	0.000198	0.000448	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SULT2A1—prostate cancer	0.000198	0.000448	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTP1—prostate cancer	0.000197	0.000446	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SLC5A5—prostate cancer	0.000195	0.000442	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MED12—prostate cancer	0.000195	0.00044	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ITPR1—prostate cancer	0.000194	0.000438	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GNG5—prostate cancer	0.000193	0.000437	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP2E1—prostate cancer	0.000191	0.000432	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.00019	0.000431	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NQO1—prostate cancer	0.000189	0.000427	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLAU—prostate cancer	0.000188	0.000426	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—TH—prostate cancer	0.000186	0.000421	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA3—prostate cancer	0.000186	0.000421	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000185	0.000418	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP3A4—prostate cancer	0.000184	0.000417	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CAV1—prostate cancer	0.000184	0.000416	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000183	0.000414	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—TYMS—prostate cancer	0.000183	0.000414	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000183	0.000414	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP1B1—prostate cancer	0.000181	0.00041	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—GSTM1—prostate cancer	0.000181	0.00041	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—prostate cancer	0.000178	0.000404	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—LPL—prostate cancer	0.000177	0.000402	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—HPGDS—prostate cancer	0.000177	0.000402	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP2C19—prostate cancer	0.000176	0.000399	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GGT1—prostate cancer	0.000175	0.000397	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NCOA1—prostate cancer	0.000173	0.000391	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ACHE—prostate cancer	0.000172	0.00039	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTT1—prostate cancer	0.000172	0.00039	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP1A1—prostate cancer	0.000171	0.000388	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ERCC2—prostate cancer	0.00017	0.000385	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP19A1—prostate cancer	0.00017	0.000385	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP2A6—prostate cancer	0.00017	0.000385	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000169	0.000384	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000169	0.000383	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CG—prostate cancer	0.000167	0.000379	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—EGF—prostate cancer	0.000166	0.000375	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKR1C3—prostate cancer	0.000165	0.000375	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PRKACB—prostate cancer	0.000165	0.000373	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—RXRA—prostate cancer	0.000164	0.000372	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000163	0.00037	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP17A1—prostate cancer	0.000163	0.000369	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000161	0.000364	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—MTHFR—prostate cancer	0.00016	0.000362	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.00016	0.000361	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—COMT—prostate cancer	0.000158	0.000358	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTP1—prostate cancer	0.000157	0.000356	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PPARA—prostate cancer	0.000157	0.000355	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CREBBP—prostate cancer	0.000155	0.000352	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA2—prostate cancer	0.000155	0.000351	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ITPR1—prostate cancer	0.000155	0.000351	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IGF1—prostate cancer	0.000153	0.000347	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000152	0.000345	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SLC5A5—prostate cancer	0.000148	0.000335	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CAV1—prostate cancer	0.000147	0.000334	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CD—prostate cancer	0.000147	0.000333	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—TYMS—prostate cancer	0.000146	0.000331	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SERPINE1—prostate cancer	0.000146	0.00033	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GSTM1—prostate cancer	0.000145	0.000327	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP2E1—prostate cancer	0.000145	0.000327	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NQO1—prostate cancer	0.000143	0.000324	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—LPL—prostate cancer	0.000142	0.000321	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TH—prostate cancer	0.000141	0.000319	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000141	0.000319	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.00014	0.000317	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP3A4—prostate cancer	0.000139	0.000316	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—NOS3—prostate cancer	0.000139	0.000315	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000139	0.000314	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP1A1—prostate cancer	0.000137	0.00031	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP1B1—prostate cancer	0.000137	0.00031	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ERCC2—prostate cancer	0.000136	0.000308	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—JAK2—prostate cancer	0.000135	0.000306	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000134	0.000304	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CG—prostate cancer	0.000134	0.000304	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GGT1—prostate cancer	0.000133	0.000301	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NCOA1—prostate cancer	0.000131	0.000296	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.00013	0.000294	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP19A1—prostate cancer	0.000129	0.000292	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CB—prostate cancer	0.000128	0.000291	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—MTHFR—prostate cancer	0.000128	0.000289	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—INS—prostate cancer	0.000127	0.000288	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PPARA—prostate cancer	0.000125	0.000284	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CREBBP—prostate cancer	0.000124	0.000282	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—RXRA—prostate cancer	0.000124	0.000282	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000121	0.000274	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—COMT—prostate cancer	0.00012	0.000271	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTP1—prostate cancer	0.000119	0.00027	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CD—prostate cancer	0.000118	0.000267	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CAV1—prostate cancer	0.000118	0.000267	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2—prostate cancer	0.000118	0.000267	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ITPR1—prostate cancer	0.000117	0.000266	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000115	0.000261	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000113	0.000255	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—NOS3—prostate cancer	0.000111	0.000252	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—TYMS—prostate cancer	0.000111	0.000251	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GSTM1—prostate cancer	0.00011	0.000248	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—LPL—prostate cancer	0.000108	0.000244	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CG—prostate cancer	0.000107	0.000243	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—EP300—prostate cancer	0.000106	0.000239	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP1A1—prostate cancer	0.000104	0.000235	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—ERCC2—prostate cancer	0.000103	0.000233	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CB—prostate cancer	0.000103	0.000233	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SRC—prostate cancer	0.000103	0.000233	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTGS2—prostate cancer	0.000102	0.000231	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—INS—prostate cancer	0.000102	0.00023	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—VEGFA—prostate cancer	0.0001	0.000227	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CREBBP—prostate cancer	9.95e-05	0.000225	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—MTHFR—prostate cancer	9.68e-05	0.000219	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PPARA—prostate cancer	9.5e-05	0.000215	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CD—prostate cancer	9.44e-05	0.000214	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TGFB1—prostate cancer	9.19e-05	0.000208	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CAV1—prostate cancer	8.93e-05	0.000202	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—NOS3—prostate cancer	8.91e-05	0.000202	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PTEN—prostate cancer	8.89e-05	0.000201	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.53e-05	0.000193	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—KRAS—prostate cancer	8.51e-05	0.000193	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—EP300—prostate cancer	8.48e-05	0.000192	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CB—prostate cancer	8.23e-05	0.000186	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTGS2—prostate cancer	8.15e-05	0.000185	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CG—prostate cancer	8.14e-05	0.000184	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PIK3CA—prostate cancer	7.82e-05	0.000177	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—INS—prostate cancer	7.7e-05	0.000174	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TP53—prostate cancer	7.57e-05	0.000171	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CREBBP—prostate cancer	7.54e-05	0.000171	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CD—prostate cancer	7.15e-05	0.000162	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PTEN—prostate cancer	7.11e-05	0.000161	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—EP300—prostate cancer	6.78e-05	0.000154	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—NOS3—prostate cancer	6.75e-05	0.000153	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—AKT1—prostate cancer	6.39e-05	0.000145	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—PIK3CA—prostate cancer	6.27e-05	0.000142	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CB—prostate cancer	6.23e-05	0.000141	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTGS2—prostate cancer	6.18e-05	0.00014	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PTEN—prostate cancer	5.39e-05	0.000122	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—EP300—prostate cancer	5.14e-05	0.000116	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—AKT1—prostate cancer	5.12e-05	0.000116	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—PIK3CA—prostate cancer	5.01e-05	0.000114	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—AKT1—prostate cancer	4.1e-05	9.28e-05	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—PIK3CA—prostate cancer	3.8e-05	8.61e-05	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—AKT1—prostate cancer	3.1e-05	7.03e-05	CbGpPWpGaD
